Egger H J, Fischer G
Biological Pharmaceutical Research Department, F. Hoffman-La Roche & Co. Ltd., Basle, Switzerland.
J Chromatogr. 1987 Sep 25;420(2):357-72. doi: 10.1016/0378-4347(87)80191-3.
A sensitive and selective high-performance liquid chromatography method has been developed for the determination of the new monocyclic beta-lactam antibiotic carumonam in plasma and urine. The method for plasma involves protein precipitation with acetonitrile and removal of lipids with dichloromethane; urine is diluted with buffer. Separation and quantification are achieved using a mobile phase based on either ion-suppression or ion-pair chromatography on a reversed-phase column with UV detection. The limit of determination is 0.5 micrograms/ml plasma, using a 0.5-ml specimen, and 25 micrograms/ml urine, using a 50-microliter specimen. The inter-assay reproducibility is generally better than 4% when an internal standard is used. Since beta-lactam antibiotics may degrade on storage, close attention must be paid to the stability of these drugs in biological fluids; novel measures to prevent degradation on storage are described. The assay has been successfully applied to the analysis of several thousand samples from pharmacokinetic studies, including a study involving patients with impaired renal function.
已开发出一种灵敏且具选择性的高效液相色谱法,用于测定血浆和尿液中的新型单环β-内酰胺抗生素卡芦莫南。血浆检测方法包括用乙腈进行蛋白沉淀,并用二氯甲烷去除脂质;尿液则用缓冲液稀释。在反相柱上,基于离子抑制或离子对色谱法,采用含紫外检测的流动相实现分离和定量。使用0.5毫升样本时,血浆的测定限为0.5微克/毫升;使用50微升样本时,尿液的测定限为25微克/毫升。使用内标时,批间重现性通常优于4%。由于β-内酰胺抗生素在储存时可能会降解,因此必须密切关注这些药物在生物流体中的稳定性;文中描述了防止储存时降解的新措施。该检测方法已成功应用于数千份药代动力学研究样本的分析,包括一项涉及肾功能受损患者的研究。